Response Rates and Survival Prediction in Metastasizing Bladder Cancer after Neoadjuvant Chemotherapy

被引：0
|
作者：
Fleischmann, A. [1 ]
Perren, A. [1 ]
Thalmann, G. N. [1 ]
Seiler, R. [1 ]
机构：
[1] Univ Bern, Bern, Switzerland
来源：
MODERN PATHOLOGY | 2014年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
936
引用
收藏
页码：228A / 228A
页数：1
相关论文
共 50 条
  • [1] Response Rates and Survival Prediction in Metastasizing Bladder Cancer after Neoadjuvant Chemotherapy
    Fleischmann, A.
    Perren, A.
    Thalmann, G. N.
    Seiler, R.
    LABORATORY INVESTIGATION, 2014, 94 : 228A - 228A
  • [2] Bladder Cancer Survival Times after neoadjuvant Chemotherapy
    Gakis, Georgios
    AKTUELLE UROLOGIE, 2016, 47 (06) : 439 - U67
  • [3] Predicting Response to Neoadjuvant Chemotherapy in Bladder Cancer
    Motterle, Giovanni
    Andrews, Jack R.
    Morlacco, Alessandro
    Karnes, R. Jeffrey
    EUROPEAN UROLOGY FOCUS, 2020, 6 (04): : 642 - 649
  • [4] Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
    Seiler, Roland
    Ashab, Hussam Al Deen
    Erho, Nicholas
    van Rhijn, Bas W. G.
    Winters, Brian
    Douglas, James
    Van Kessel, Kim E.
    van de Putte, Elisabeth E. Fransen
    Sommerlad, Matthew
    Wang, Natalie Q.
    Choeurng, Voleak
    Gibb, Ewan A.
    Palmer-Aronsten, Beatrix
    Lam, Lucia L.
    Buerki, Christine
    Davicioni, Elai
    Sjodahl, Gottfrid
    Kardos, Jordan
    Hoadley, Katherine A.
    Lerner, Seth P.
    McConkey, David J.
    Choi, Woonyoung
    Kim, William Y.
    Kiss, Bernhard
    Thalmann, George N.
    Todenhofer, Tilman
    Crabb, Simon J.
    North, Scott
    Zwarthoff, Ellen C.
    Boormans, Joost L.
    Wright, Jonathan
    Dall'Era, Marc
    van der Heijden, Michiel S.
    Black, Peter C.
    EUROPEAN UROLOGY, 2017, 72 (04) : 544 - 554
  • [5] The Impact of Body Mass Index on Pathological Response and Survival Outcome after Neoadjuvant Chemotherapy in Localized Bladder Cancer
    Mohammed, Amrallah
    Elsayed, Fifi
    Salem, Reham
    MIDDLE EAST JOURNAL OF CANCER, 2023, 14 (01) : 136 - 145
  • [6] Quality of Pathologic Response and Surgery Correlate With Survival for Patients With Completely Resected Bladder Cancer After Neoadjuvant Chemotherapy
    Sonpavde, Guru
    Goldman, Bryan H.
    Speights, V. O.
    Lerner, Seth P.
    Wood, David P.
    Vogelzang, Nicholas J.
    Trump, Donald L.
    Natale, Ronald B.
    Grossman, H. Barton
    Crawford, E. David
    CANCER, 2009, 115 (18) : 4104 - 4109
  • [7] Tumour regression after neoadjuvant chemotherapy independently predicts survival in urothelial cancer of the bladder
    Seiler, R.
    Fleischmann, A.
    Thalmann, G. N.
    EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E557 - U199
  • [8] Tumor Regression after Neoadjuvant Chemotherapy Independently Predicts Survival in Bladder Cancer Patients
    Fleischmann, A.
    Perren, A.
    Thalmann, G. N.
    Seiler, R.
    MODERN PATHOLOGY, 2012, 25 : 205A - 205A
  • [9] Tumor Regression after Neoadjuvant Chemotherapy Independently Predicts Survival in Bladder Cancer Patients
    Fleischmann, A.
    Perren, A.
    Thalmann, G. N.
    Seiler, R.
    LABORATORY INVESTIGATION, 2012, 92 : 205A - 205A
  • [10] BLADDER CANCER PATIENTS WITHOUT PATHOLOGIC RESPONSE TO NEOADJUVANT CHEMOTHERAPY EXPERIENCE LOWER SURVIVAL RATES THAN RADICAL CYSTECTOMY ALONE
    Pfail, John
    Audenet, Francois
    Martini, Alberto
    Attalla, Kyrollis
    Waingankar, Nikhil
    Galsky, Matthew
    Sfakianos, John
    JOURNAL OF UROLOGY, 2019, 201 (04): : E444 - E445
12345